Clinical Utility of Botulinum Toxin Injections in Children with Gastrointestinal Disorders

Area of Science:

• Pediatric Gastroenterology
• Gastrointestinal Motility Disorders
• Minimally Invasive Procedures

Background:

• Botulinum toxin (BTX) is an acetylcholine inhibitor used for sphincter dysfunction.
• Pediatric gastrointestinal (GI) disorders often involve motility issues and sphincter dysfunction.

Purpose of the Study:

• To review the clinical utility of botulinum toxin (BTX) injections in children with GI disorders.
• To assess the effectiveness and limitations of BTX in pediatric GI conditions.

Main Methods:

• Literature review of studies on BTX injections for pediatric GI disorders.
• Analysis of BTX applications in esophageal, pyloric, and anorectal conditions.

Main Results:

• BTX injections show promise for cricopharyngeal achalasia, achalasia, gastroparesis, and obstructive defecation in children.
• The treatment is minimally invasive, reversible, and generally well-tolerated with mild side effects.
• Limitations include transient effects, procedural variability, and predominantly off-label use with limited pediatric data.

Conclusions:

• BTX injections represent a viable, albeit temporary, treatment option for select pediatric GI motility disorders.
• Further prospective studies are essential to standardize protocols, determine optimal dosing, and establish long-term efficacy.
• Patient selection and understanding of BTX's role in managing complex pediatric GI conditions require further investigation.